3 People watching this product now
Product Overview Retatrutide (RETA-10) 112mg research peptide is supplied exclusively for laboratory and analytical research purposes
The mutation of GIPR Glu 354 to Gln increases GIP affinity, enhances the agonist residence time by 25%, increases cAMP activity, and facilitates the rate of internalization by 2.12.3-fold
Its tailored for patients aiming to leverage insurance for comprehensive care
The compound demonstrates extended stability with a prolonged half-life, making it suitable for weekly intervals in research protocols
Has a licensed pharmacist on staff to answer your questions Affordability (yes, here too): While price breaks on GLP-1s may seem like a welcomed relief, prioritizing price as the main factor in using compounded formulations does not account for safety and efficacy